Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Samsung Biologics
Sort By
Newest First
1 / 3
1 / 3
sustainability
Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index
Samsung Biologics
PR-12-24-NI-138
Dec 17, 2024
AI
AI Implementation to Enhance Quality
Seongil Cho; Hyeokgeon Kwon; Kisung Shim
Samsung Biologics
PAO-12-24-CL-5
Dec 13, 2024
Decarbonization
Samsung Biologics Hosts ESG Event with Suppliers to Strengthen Decarbonization Efforts
Samsung Biologics
PR-12-24-NI-127
Dec 03, 2024
Lyophilization
Enhancing Biopharmaceutical Stability Through Lyophilization
David King; Hoju Lee; Sungjin Park; Yeonju Yoon
Samsung Biologics
PAO-11-24-CL-08
Nov 26, 2024
Clinical Trials
Samsung Biologics earns ISO certifications in recognition of business excellence
Samsung Biologics
PR-10-24-NI-86
Nov 08, 2024
Innovation
How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?
Pharma's Almanac
PAO-11-24-RT-02
Oct 28, 2024
Financing
Samsung Biologics reports third quarter 2024 financial results
Samsung Biologics
PR-10-24-NI-58
Oct 23, 2024
CDMO
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
Samsung Biologics
PR-10-24-NI-41
Oct 14, 2024
RNA
Optimized Residual dsRNA Detection for mRNA Therapeutics
Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang
Samsung Biologics
PAO-09-24-CL-07
Sep 30, 2024
Developability
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Heonchang Lim
Samsung Biologics
PAO-09-24-CL-04
Sep 04, 2024
Sequence Variants
Accelerating Protein Sequence Variant Analysis
Kyoungmin Lee; Yunjeong Heo; Jongbae Park
Samsung Biologics
PAO-08-24-CL-08
Aug 13, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01
Aug 07, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02
Aug 07, 2024
Regulatory
Building a Path to Approval with Effective Regulatory Support
Mira Han
Samsung Biologics
PAO-07-24-CL-12
Jul 29, 2024
Trusted Partnerships
Partnerships for Success
Ryan Lee
Samsung Biologics
PAO-06-24-CL-08
Jun 25, 2024
Digitalization
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
Pharma's Almanac
PAO-06-24-RT-02
Jun 24, 2024
Investment
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Pharma's Almanac
PAO-06-24-RT-01
Jun 24, 2024
Down Stream Processing
Expediting Biologics Drug Development: Downstream Strategies to Accelerate Preclinical Development Timelines
Songyoung Kim
Samsung Biologics
PAO-04-24-CL-05
Apr 17, 2024
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03
Mar 08, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02
Mar 08, 2024
